You are here

Article info

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer

Authors

  • Yang Shen National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China Department of oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China PubMed articlesGoogle scholar articles
  • Yongsheng Teng National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Yipin Lv National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Yongliang Zhao Department of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Yuan Qiu Department of General Surgery of Xinqiao Hospital, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Weisan Chen La Trobe Institute for Molecular Science, School of Molecular Science, La Trobe University, Bundoora, Victoria, Australia PubMed articlesGoogle scholar articles
  • Lina Wang National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Ying Wang National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Fangyuan Mao National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Ping Cheng National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Daiyuan Ma Department of oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China PubMed articlesGoogle scholar articles
  • Yuan Zhuang National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Quanming Zou National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles
  • Liusheng Peng National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China PubMed articlesGoogle scholar articles

Citation

Shen Y, Teng Y, Lv Y, et al
PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer
Journal for ImmunoTherapy of Cancer 2020;8:e000422. doi: 10.1136/jitc-2019-000422
Online issue publication 
August 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.